Alcon AG | ALC - Себестоимость





Себестоимость Изменить Дата
AstraZeneca USD 2.52B 2.73B 2026-06
Bayer EUR 4.54B 692M 2026-06
Essilor EUR 5.55B 505M 2026-06
Fresenius EUR 4.4B 111M 2026-06
Fresenius Medical Care EUR 3.55B 117.58M 2026-06
GlaxoSmithKline GBP 2.07B 192M 2026-06
GRIFOLS EUR 1.17B 90M 2026-06
Lonza CHF 2.28B 189M 2025-06
Merck EUR 2.27B 199M 2026-06
Novartis USD 3.71B 251M 2026-06
Philips EUR 2.21B 70M 2026-06
Roche Holding CHF 7.85B 630M 2026-06
Sanofi EUR 3.02B 656M 2026-06
Smith & Nephew USD 901M 31M 2026-06
Sonova Holding CHF 539.4M 11.5M 2025-12
UCB EUR 1.07B 146M 2025-12